To identify patients whose tumours harbour a subclonal T790M mutation, patients with both an activating EGFR mutation and T790M detectable in cfDNA (n = 184) were included in the analysis (Fig. 1c and Supplementary Fig. 3). This evidence concerns the gene EGFR and neoplasm.